<DOC>
	<DOC>NCT01657201</DOC>
	<brief_summary>The purpose of this study is to evaluate the pharmacokinetic properties and safety of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend).</brief_summary>
	<brief_title>Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)</brief_title>
	<detailed_description />
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Healthy adults 2045 years of age Weight of ≥ 60kg ≤ 90kg with BMI of ≥ 19 and &lt; 27 (BMI(kg/m2)= weight(kg)/{height(m)}2 Voluntary written informed consent History or presence of significant renal, neurologic, pulmonary, endocrine, hematology, oncology, urologic, cardiovascular, musculoskeletal or psychiatric disease Drug allergies to Voriconazole Recent history or evidence of drug abuse Recent participation(within 2 months) in other clinical studies Recent donation of blood(within 2months), plasma(within 1month) or transfusion(within 1month)</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>